Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical lidocaine-prilocaine versus infiltrative lidocaine for pain control during thoracentesis and abdominocentesis
IRCT20191204045600N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of lidocaine + prilocaine and lidocaine in pleural effusion and ascites (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Patients' pain and Patient satisfaction. Started Feb 2019; status: completed.
02
Drugs
lidocaine + prilocainelidocaine
03
Conditions
pleural effusionascites
Beyond the preview
Go deeper on IRCT20191204045600N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191204045600N1.